CYP3A4 and MDR1 Alleles in a Portuguese Population

Verfasser / Beitragende:
[Isa Cavaco, J. Pedro Gil, Eva Gil-Berglund, Vera Ribeiro]
Ort, Verlag, Jahr:
2003
Enthalten in:
Clinical Chemistry and Laboratory Medicine, 41/10(2003-09-19), 1345-1350
Format:
Artikel (online)
ID: 378849352
LEADER caa a22 4500
001 378849352
003 CHVBK
005 20180305123319.0
007 cr unu---uuuuu
008 161128e20030919xx s 000 0 eng
024 7 0 |a 10.1515/CCLM.2003.206  |2 doi 
035 |a (NATIONALLICENCE)gruyter-10.1515/CCLM.2003.206 
245 0 0 |a CYP3A4 and MDR1 Alleles in a Portuguese Population  |h [Elektronische Daten]  |c [Isa Cavaco, J. Pedro Gil, Eva Gil-Berglund, Vera Ribeiro] 
520 3 |a Polymorphisms in cytochrome P450 CYP3A4 and multidrug resistance (MDR)1 genes coding for the important drugmetabolising CYP3A4 and the ATP-binding cassette (ABC) transporter P-glycoprotein (Pgp) are poorly documented in the Portuguese population. In this study we have determined the frequencies of CYP3A4 and MDR1 alleles in Portuguese Caucasians. Both genes were simultaneously analysed as these genes are known to be frequently co-induced and their products to show a pronounced overlap of substrates. CYP3A4 A-392G (CYP3A4*1B), T673C (CYP3A4*2) and MDR1 T-129C, G2677T and C3435T single nucleotide polymorphisms (SNPs) were analysed in 100 individuals from the southern region of the country. We observed a frequency of 4.0% for CYP3A4*1B, not significantly different from that reported on other Caucasian European populations. CYP3A4*2 was found at an allele frequency of 4.5%, constituting the first report of the presence of this allele outside the Finnish population. Significant differences were found concerning the MDR1 C3435T SNP frequency (64.5%) compared with other European populations, while no differences were found concerning G2677T (47.5%) or T-129C (5%) SNPs. Linkage between the C3435T and G2677T SNPs was observed, although not as evidently as documented in other Caucasian populations. No preferential associations were detected between CYP3A4 and MDR1 alleles. Clin Chem Lab Med 2003; 41(10):13451350 
540 |a Copyright © 2003 by Walter de Gruyter GmbH & Co. KG 
690 7 |a Medical equipment & techniques  |2 nationallicence 
690 7 |a Medical diagnosis  |2 nationallicence 
690 7 |a Diseases & disorders  |2 nationallicence 
700 1 |a Cavaco  |D Isa  |4 aut 
700 1 |a Gil  |D J. Pedro  |4 aut 
700 1 |a Gil-Berglund  |D Eva  |4 aut 
700 1 |a Ribeiro  |D Vera  |4 aut 
773 0 |t Clinical Chemistry and Laboratory Medicine  |d Walter de Gruyter  |g 41/10(2003-09-19), 1345-1350  |x 1434-6621  |q 41:10<1345  |1 2003  |2 41  |o cclm 
856 4 0 |u https://doi.org/10.1515/CCLM.2003.206  |q text/html  |z Onlinezugriff via DOI 
908 |D 1  |a research article  |2 jats 
950 |B NATIONALLICENCE  |P 856  |E 40  |u https://doi.org/10.1515/CCLM.2003.206  |q text/html  |z Onlinezugriff via DOI 
950 |B NATIONALLICENCE  |P 700  |E 1-  |a Cavaco  |D Isa  |4 aut 
950 |B NATIONALLICENCE  |P 700  |E 1-  |a Gil  |D J. Pedro  |4 aut 
950 |B NATIONALLICENCE  |P 700  |E 1-  |a Gil-Berglund  |D Eva  |4 aut 
950 |B NATIONALLICENCE  |P 700  |E 1-  |a Ribeiro  |D Vera  |4 aut 
950 |B NATIONALLICENCE  |P 773  |E 0-  |t Clinical Chemistry and Laboratory Medicine  |d Walter de Gruyter  |g 41/10(2003-09-19), 1345-1350  |x 1434-6621  |q 41:10<1345  |1 2003  |2 41  |o cclm 
900 7 |b CC0  |u http://creativecommons.org/publicdomain/zero/1.0  |2 nationallicence 
898 |a BK010053  |b XK010053  |c XK010000 
949 |B NATIONALLICENCE  |F NATIONALLICENCE  |b NL-gruyter